|
|
 |
|
Viewing report
|
|
|
|
U.S. Cardiac Rhythm Management Markets
Frost & Sullivan, March 2006
This Frost & Sullivan research service entitled U.S. Cardiac Rhythm Management Market provides an overview of the trends and technologies that have shaped market revenue, market share, and implantation rates in the individual segments of the CRM market. The study thoroughly examines the following segments of the market: pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy devices, and cardiac ablation systems.
Market Sector
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research service:
- Pacemakers
- Implantable cardioverter defibrillators
- Cardiac resynchronization therapy devices
- Cardiac ablation systems
Technologies
The following technologies are covered in this research service:
- Cryoablation
- Laser ablation
- Home monitoring
- Implantable biosensors
- Rate adaptive pacing
Market Overview
Imaging Developments Boost Confidence in Device Therapy for Cardiac Rhythm Management (CRM)
Significant advancements in imaging technology have improved the accuracy and safety of cardiac surgery and device implantation, and in turn, increased the number of approvable procedures to correct cardiac arrhythmia. Due to such developments, real-time monitoring of both heart anatomy and function before and during surgery is now possible. Sophisticated imaging technologies currently in use include computed tomography (CT), ultrasound, angiography, and intra-cardial echo, all of which have enabled cardiac surgery to become far more advanced. With improved surgical capabilities, the safety of procedures has also increased, directly impacting the number of devices and procedures that are approved and reimbursed.
Advanced imaging techniques that can more accurately identify disease states ensure that the patients in most need are receiving appropriate therapy, in addition to improving surgical procedures through accurate catheter targeting and device lead placement, notes the analyst of this research service. Improving the arsenal and accuracy of minimally invasive techniques is therefore, likely to have a major impact on the CRM devices market in both the short and long term future.
Higher Incidences of Arrhythmia Create Need for Advanced Device Therap
Due to sustained research and continuous advancements in technology, cardiac rhythm management devices have not only become smaller and more efficient, but also perform with greater autonomy. Current implantable devices are far more refined than those available previously. They have the capability to not only significantly prolong life expectancy of a patient, but also drastically enhance the quality of life for that individual. Most importantly, these sophisticated devices with advanced features such as rate adaptive pacing and remote patient monitoring offer increased autonomous care and therapy without the need for excessive hospital visits and disruptions to personal life in order to adjust device settings.
These improvements in technology coincide with the rapidly increasing number of patients that will require interventional CRM therapy. The growing prevalence of heart disease and arrhythmia disorders leading to sudden cardiac arrest has heightened the need for advanced and efficient medical device therapy, says the analyst. As patient demand continues to surge and technology continues to progress at a rapid pace, this is expected to open up new opportunities for the CRM market.
|
|
|
|
